Edmunds, Laurel D.
Gluderer, Silvia
Ovseiko, Pavel V.
Kamerling, Roel
Ton, Jacqueline
Vis, Laura
Jenni, Mario
Tutton, Gregory
Lawton-Smith, Helen
Nadabán, Márta Völgyiné
Rab, Máté
Rees, Jon
Anson, John
Rushforth, Alexander D.
Allen, Maxine
Buchan, Alastair M.
Vendrell, Montserrat
Casta, Alex
Mehes, Gábor
Hogendoorn, Pancras C. W.
Hafen, Ernst
Hassan, A. Bassim
Funding for this research was provided by:
Seventh Framework Programme (265550)
European Institute of Innovation and Technology (EIT Health-Rare Cancer KIC Stage 1)
Health Services Research Programme (Oxford Biomedical Research Centre)
Article History
Received: 25 July 2018
Accepted: 7 January 2019
First Online: 28 January 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: EH is a director of evalueSCIENCE Ltd., PCWH and ABH are advisors. The other authors declare no financial competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.